• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    Four DF/HCC Members Elected to the Institute of Medicine

    October 23, 2014

    The Institute of Medicine (IOM) recently announced 70 new members, four of which are DF/HCC researchers

    DF/HCC CURE Program Celebrates Thirteen Years of Success

    October 2014 | eNews

    This year, 32 Scholars participated in the NCI Continuing Umbrella of Research Experiences (CURE) program, a hands-on research training experience for high school and college students from underrepresented populations

    Using Mathematics to Predict the Best Dose

    October 2014 | eNews

    Franziska Michor, PhD (DFCI), applies mathematical modeling to try to predict how cancers accumulate mutations and other changes and how these might affect response to treatment

    Enzalutamide Plus EBRT as a Novel Treatment Approach in Intermediate Risk Prostate Cancer

    October 2014 | eNews

    Only about 10% of men with prostate cancer present with metastatic disease at the time of diagnosis

    Mining “Big Data” to Improve Research Approaches in Cancer

    October 2014 | eNews

    For years, the classic paradigm for evaluating new cancer drugs has been to compare two patient groups—one treated with an experimental approach and the other with the current standard of care—while keeping other variables, such as patient and disease characteristics, as similar as possible

    Community Practice Research Core

    October 2014 | eNews

    The Community Practice Research Core (CPRC) offers DF/HCC researchers an opportunity to work on cancer-related projects in real-world community settings

    The 2014 Mazzone Awards Program Funds Prostate Cancer Research with Disparities Focus

    October 2014 | eNews

    Dana-Farber/Harvard Cancer Center and the Prostate Cancer Foundation announce two funding recipients for the 2014 Mazzone Awards Program

Displaying results 8 to 14 out of 223